157 related articles for article (PubMed ID: 27388010)
1. Comprehensive Identification and Quantitation of Basic Building Blocks for Low-Molecular Weight Heparin.
Sun X; Sheng A; Liu X; Shi F; Jin L; Xie S; Zhang F; Linhardt RJ; Chi L
Anal Chem; 2016 Aug; 88(15):7738-44. PubMed ID: 27388010
[TBL] [Abstract][Full Text] [Related]
2. Hydrophilic interaction chromatography-multiple reaction monitoring mass spectrometry method for basic building block analysis of low molecular weight heparins prepared through nitrous acid depolymerization.
Sun X; Guo Z; Yu M; Lin C; Sheng A; Wang Z; Linhardt RJ; Chi L
J Chromatogr A; 2017 Jan; 1479():121-128. PubMed ID: 27923477
[TBL] [Abstract][Full Text] [Related]
3. Liquid chromatography-diode array detection-mass spectrometry for compositional analysis of low molecular weight heparins.
Wang Z; Li D; Sun X; Bai X; Jin L; Chi L
Anal Biochem; 2014 Apr; 451():35-41. PubMed ID: 24530286
[TBL] [Abstract][Full Text] [Related]
4. [Determination of sulfation degree of heparin and low molecular weight heparins by capillary electrophoresis].
Shen Y; Kang J
Se Pu; 2020 Oct; 38(10):1238-1242. PubMed ID: 34213122
[TBL] [Abstract][Full Text] [Related]
5. Fragment profiling of low molecular weight heparins using reversed phase ion pair liquid chromatography-electrospray mass spectrometry.
Xu X; Li D; Chi L; Du X; Bai X; Chi L
Carbohydr Res; 2015 Apr; 407():26-33. PubMed ID: 25701653
[TBL] [Abstract][Full Text] [Related]
6. Structural features of glycol-split low-molecular-weight heparins and their heparin lyase generated fragments.
Alekseeva A; Casu B; Cassinelli G; Guerrini M; Torri G; Naggi A
Anal Bioanal Chem; 2014 Jan; 406(1):249-65. PubMed ID: 24253408
[TBL] [Abstract][Full Text] [Related]
7. Product individuality of commercially available low-molecular-weight heparins and their generic versions: therapeutic implications.
Maddineni J; Walenga JM; Jeske WP; Hoppensteadt DA; Fareed J; Wahi R; Bick RL
Clin Appl Thromb Hemost; 2006 Jul; 12(3):267-76. PubMed ID: 16959680
[TBL] [Abstract][Full Text] [Related]
8. Structural analysis of low molecular weight heparin by ultraperformance size exclusion chromatography/time of flight mass spectrometry and capillary zone electrophoresis.
Zhang Q; Chen X; Zhu Z; Zhan X; Wu Y; Song L; Kang J
Anal Chem; 2013 Feb; 85(3):1819-27. PubMed ID: 23273485
[TBL] [Abstract][Full Text] [Related]
9. Qualitative and quantitative analysis of 2, 5-anhydro-d-mannitol in low molecular weight heparins with high performance anion exchange chromatography hyphenated quadrupole time of flight mass spectrometry.
Yi L; Zhang Q; Meng Y; Hao J; Xie B; Gan H; Li D; Dong K; Zhang Z
J Chromatogr A; 2018 Sep; 1569():160-167. PubMed ID: 30055911
[TBL] [Abstract][Full Text] [Related]
10. Qualitative and quantitative analysis of heparin and low molecular weight heparins using size exclusion chromatography with multiple angle laser scattering/refractive index and inductively coupled plasma/mass spectrometry detectors.
Ouyang Y; Zeng Y; Yi L; Tang H; Li D; Linhardt RJ; Zhang Z
J Chromatogr A; 2017 Nov; 1522():56-61. PubMed ID: 28958760
[TBL] [Abstract][Full Text] [Related]
11. Quantitative determination of disaccharide content in digested unfragmented heparin and low molecular weight heparin by direct-infusion electrospray mass spectrometry.
Camara JE; Satterfield MB; Nelson BC
J Pharm Biomed Anal; 2007 Apr; 43(5):1706-14. PubMed ID: 17275239
[TBL] [Abstract][Full Text] [Related]
12. Analysis of heparinase derived LMWH products using a MHC 2D LC system linked to Q-TOF MS.
Chen L; Zhu W; Yan N; Guo Y; Yi L; Ouyang Y; Zhang Z
J Pharm Biomed Anal; 2022 Apr; 212():114616. PubMed ID: 35149417
[TBL] [Abstract][Full Text] [Related]
13. Development of hydrophilic interaction chromatography with quadruple time-of-flight mass spectrometry for heparin and low molecular weight heparin disaccharide analysis.
Ouyang Y; Wu C; Sun X; Liu J; Linhardt RJ; Zhang Z
Rapid Commun Mass Spectrom; 2016 Jan; 30(2):277-84. PubMed ID: 26689158
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic synthesis of low molecular weight heparins from N-sulfo heparosan depolymerized by heparanase or heparin lyase.
Yu Y; Fu L; He P; Xia K; Varghese S; Dordick J; Wang H; Zhang F; Linhardt RJ
Carbohydr Polym; 2022 Nov; 295():119825. PubMed ID: 35988993
[TBL] [Abstract][Full Text] [Related]
15. Bottom-up low molecular weight heparin analysis using liquid chromatography-Fourier transform mass spectrometry for extensive characterization.
Li G; Steppich J; Wang Z; Sun Y; Xue C; Linhardt RJ; Li L
Anal Chem; 2014 Jul; 86(13):6626-32. PubMed ID: 24905078
[TBL] [Abstract][Full Text] [Related]
16. Mapping of low molecular weight heparins using reversed phase ion pair liquid chromatography-mass spectrometry.
Li D; Chi L; Jin L; Xu X; Du X; Ji S; Chi L
Carbohydr Polym; 2014 Jan; 99():339-44. PubMed ID: 24274516
[TBL] [Abstract][Full Text] [Related]
17. Antithrombin III-Binding Site Analysis of Low-Molecular-Weight Heparin Fractions.
Chen Y; Zhao J; Yu Y; Liu X; Lin L; Zhang F; Linhardt RJ
J Pharm Sci; 2018 May; 107(5):1290-1295. PubMed ID: 29339133
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of antithrombin III binding site in low molecular weight heparins by exhausetive heparinases digestion and capillary electrophoresis.
Zhang M; Li G; Zhang Y; Kang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():78-83. PubMed ID: 29031112
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Low-Molecular-Weight Heparins by Strong Anion-Exchange Chromatography.
Sadowski R; Gadzała-Kopciuch R; Kowalkowski T; Widomski P; Jujeczka L; Buszewski B
J AOAC Int; 2017 Nov; 100(6):1706-1714. PubMed ID: 28707621
[TBL] [Abstract][Full Text] [Related]
20. Characterization of currently marketed heparin products: analysis of molecular weight and heparinase-I digest patterns.
Sommers CD; Ye H; Kolinski RE; Nasr M; Buhse LF; Al-Hakim A; Keire DA
Anal Bioanal Chem; 2011 Nov; 401(8):2445-54. PubMed ID: 21901459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
